{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:55:55Z","timestamp":1791262555739,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016691","name":"Guangdong Provincial Pearl River Talents Program","doi-asserted-by":"publisher","award":["2017GC010361"],"award-info":[{"award-number":["2017GC010361"]}],"id":[{"id":"10.13039\/100016691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22001048"],"award-info":[{"award-number":["22001048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110534","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:07:26Z","timestamp":1789427246000},"page":"110534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel Brevilin A derivatives as antitumor agents"],"prefix":"10.1016","volume":"182","author":[{"given":"Liangxi","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Kuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huicai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110534_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155825","article-title":"Centipeda minima and 6-O-angeloylplenolin enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer","volume":"132","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2026.110534_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115027","article-title":"Centipeda minima: an update on its phytochemistry, pharmacology and safety","volume":"292","author":"Tan","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2026.110534_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154397","article-title":"Promising anticancer activities and mechanisms of action of active compounds from the medicinal herb Centipeda minima (L.) A. Braun & Asch","volume":"106","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110534_bb0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13020-023-00870-1","article-title":"Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones","volume":"18","author":"Cao","year":"2023","journal-title":"Chin. Med."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110534_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30204072","article-title":"Centipeda minima: a review of phytochemistry, pharmacology, and predictive analysis on quality markers","volume":"30","author":"Shang","year":"2025","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110534_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acs.jnatprod.0c00884","article-title":"Cytotoxic and anti-inflammatory sesquiterpenes from the whole plants of Centipeda minima","volume":"84","author":"Xue","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110534_bb0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpba.2019.05.067","article-title":"Qualitative and quantitative analysis of sesquiterpene lactones in Centipeda minima by UPLC-orbitrap-MS & UPLC-QQQ-MS","volume":"174","author":"Chan","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110534_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18488","article-title":"Brevilin a exerts anti-colorectal cancer effects and potently inhibits STAT3 signaling invitro","volume":"9","author":"Meng","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110534_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-025-03629-1","article-title":"Brevilin a, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15\/STAT3 signaling pathway","volume":"27","author":"Qiao","year":"2025","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110534_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12967-023-04087-6","article-title":"Brevilin a is a potent anti-metastatic CRC agent that targets the VEGF-IL6-STAT3 axis in the HSCs-CRC interplay","volume":"21","author":"Fan","year":"2023","journal-title":"J. Transl. Med."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110534_bb0055","article-title":"Brevilin a isolated from Centipeda minima induces apoptosis in human gastric Cancer cells via an extrinsic apoptotic Signaling pathway","volume":"11","author":"Lee","year":"2022","journal-title":"Plants (Basel)."},{"issue":"33","key":"10.1016\/j.bioorg.2026.110534_bb0060","doi-asserted-by":"crossref","first-page":"34953","DOI":"10.18632\/oncotarget.5547","article-title":"Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110534_bb0065","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.18632\/oncotarget.13153","article-title":"Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110534_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/15384101.2024.2309005","article-title":"Entero-toxigenic Bacteroides fragilis contributes to intestinal barrier injury and colorectal cancer progression by mediating the BFT\/STAT3\/ZEB2 pathway","volume":"23","author":"Yang","year":"2024","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2026.110534_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157386","article-title":"Brevilin a suppresses lipid metabolism reprogramming in colorectal adenoma-to-adenocarcinoma sequence via the NR1D1\/APOH signaling axis","volume":"148","author":"Tang","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110534_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12974","article-title":"STAT3 and its targeting inhibitors in osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110534_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110534_bb0090","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioorg.2026.110534_bb0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2019.10.005","article-title":"Novel activators and small-molecule inhibitors of STAT3 in cancer","volume":"49","author":"Yang","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110534_bb0100","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of small-molecule STAT3 inhibitors for Cancer therapy: from phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110534_bb0105","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.7150\/jca.40983","article-title":"Brevilin a induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells","volume":"11","author":"Khan","year":"2020","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110534_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1389450119666181012125230","article-title":"A sesquiterpene lactone with multidirectional activity","volume":"20","author":"Drogosz","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2026.110534_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phytochem.2012.01.003","article-title":"Supercritical fluid extraction assisted isolation of sesquiterpene lactones with antiproliferative effects from Centipeda minima","volume":"76","author":"Wu","year":"2012","journal-title":"Phytochemistry"},{"issue":"24","key":"10.1016\/j.bioorg.2026.110534_bb0120","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1021\/acsomega.0c01276","article-title":"Synthesis and evaluation of novel anticancer compounds derived from the natural product Brevilin A","volume":"5","author":"Lee","year":"2020","journal-title":"ACS Omega"},{"issue":"15\u201316","key":"10.1016\/j.bioorg.2026.110534_bb0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.drudis.2010.06.002","article-title":"What made sesquiterpene lactones reach cancer clinical trials?","volume":"15","author":"Ghantous","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110534_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101908","article-title":"Arnicolide D, from the herb Centipeda minima, is a therapeutic candidate against nasopharyngeal carcinoma","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110534_bb0135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bmcl.2015.11.074","article-title":"Development of a novel sulfonate ester-based prodrug strategy","volume":"26","author":"Hanaya","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110534_bb0140","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.3390\/molecules191119021","article-title":"Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents","volume":"19","author":"Wang","year":"2014","journal-title":"Molecules"},{"issue":"20","key":"10.1016\/j.bioorg.2026.110534_bb0145","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.bmcl.2015.08.064","article-title":"A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: design, synthesis, and anti-proliferative evaluation","volume":"25","author":"Chen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110534_bb0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.lungcan.2015.09.014","article-title":"Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer","volume":"90","author":"Lewis","year":"2015","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110534_bb0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cmdc.200900499","article-title":"The tunable functionality of alpha,beta-unsaturated carbonyl compounds enables their differential application in biological systems","volume":"5","author":"Amslinger","year":"2010","journal-title":"ChemMedChem"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:39:38Z","timestamp":1791261578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"alternative-id":["S0045206826010709"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110534","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel Brevilin A derivatives as antitumor agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110534"}}